China · Delayed Price · Currency is CNY Acrobiosystems Statistics
Total Valuation
Acrobiosystems has a market cap or net worth of CNY 7.95 billion. The enterprise value is 6.72 billion.
| Market Cap | 7.95B |
| Enterprise Value | 6.72B |
Important Dates
The next confirmed earnings date is Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Acrobiosystems has 167.40 million shares outstanding. The number of shares has decreased by -3.26% in one year.
| Current Share Class | 167.40M |
| Shares Outstanding | 167.40M |
| Shares Change (YoY) | -3.26% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 36.74% |
| Owned by Institutions (%) | 16.57% |
| Float | 90.32M |
Valuation Ratios
The trailing PE ratio is 45.72 and the forward PE ratio is 27.24.
| PE Ratio | 45.72 |
| Forward PE | 27.24 |
| PS Ratio | 8.96 |
| PB Ratio | 2.94 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | 56.46 |
| P/OCF Ratio | 21.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.51, with an EV/FCF ratio of 47.71.
| EV / Earnings | 39.24 |
| EV / Sales | 7.57 |
| EV / EBITDA | 24.51 |
| EV / EBIT | 31.52 |
| EV / FCF | 47.71 |
Financial Position
The company has a current ratio of 13.30, with a Debt / Equity ratio of 0.03.
| Current Ratio | 13.30 |
| Quick Ratio | 10.97 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.59 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.42% and return on invested capital (ROIC) is 14.48%.
| Return on Equity (ROE) | 6.42% |
| Return on Assets (ROA) | 4.58% |
| Return on Invested Capital (ROIC) | 14.48% |
| Return on Capital Employed (ROCE) | 7.46% |
| Weighted Average Cost of Capital (WACC) | 8.79% |
| Revenue Per Employee | 1.02M |
| Profits Per Employee | 197,061 |
| Employee Count | 869 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 0.33 |
Taxes
In the past 12 months, Acrobiosystems has paid 4.52 million in taxes.
| Income Tax | 4.52M |
| Effective Tax Rate | 2.58% |
Stock Price Statistics
The stock price has increased by +50.18% in the last 52 weeks. The beta is 0.84, so Acrobiosystems's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +50.18% |
| 50-Day Moving Average | 46.44 |
| 200-Day Moving Average | 54.30 |
| Relative Strength Index (RSI) | 48.26 |
| Average Volume (20 Days) | 5,169,641 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acrobiosystems had revenue of CNY 887.21 million and earned 171.25 million in profits. Earnings per share was 1.04.
| Revenue | 887.21M |
| Gross Profit | 808.34M |
| Operating Income | 213.18M |
| Pretax Income | 175.30M |
| Net Income | 171.25M |
| EBITDA | 263.90M |
| EBIT | 213.18M |
| Earnings Per Share (EPS) | 1.04 |
Balance Sheet
The company has 1.31 billion in cash and 82.55 million in debt, with a net cash position of 1.23 billion or 7.36 per share.
| Cash & Cash Equivalents | 1.31B |
| Total Debt | 82.55M |
| Net Cash | 1.23B |
| Net Cash Per Share | 7.36 |
| Equity (Book Value) | 2.70B |
| Book Value Per Share | 16.16 |
| Working Capital | 1.61B |
Cash Flow
In the last 12 months, operating cash flow was 362.22 million and capital expenditures -221.40 million, giving a free cash flow of 140.82 million.
| Operating Cash Flow | 362.22M |
| Capital Expenditures | -221.40M |
| Depreciation & Amortization | 50.72M |
| Net Borrowing | 3.92M |
| Free Cash Flow | 140.82M |
| FCF Per Share | 0.84 |
Margins
Gross margin is 91.11%, with operating and profit margins of 24.03% and 19.30%.
| Gross Margin | 91.11% |
| Operating Margin | 24.03% |
| Pretax Margin | 19.76% |
| Profit Margin | 19.30% |
| EBITDA Margin | 29.74% |
| EBIT Margin | 24.03% |
| FCF Margin | 15.87% |
Dividends & Yields
This stock pays an annual dividend of 0.57, which amounts to a dividend yield of 1.19%.
| Dividend Per Share | 0.57 |
| Dividend Yield | 1.19% |
| Dividend Growth (YoY) | -4.44% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 28.02% |
| Buyback Yield | 3.26% |
| Shareholder Yield | 4.45% |
| Earnings Yield | 2.15% |
| FCF Yield | 1.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 11, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Jul 11, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |